Frye RF - Search Results

1

Liver disease selectively modulates cytochrome P450--mediated metabolism.

Frye RF, Zgheib NK, Matzke GR, Chaves-Gnecco D, Rabinovitz M, Shaikh OS, Branch RA. Frye RF, et al. Clin Pharmacol Ther. 2006 Sep;80(3):235-45. doi: 10.1016/j.clpt.2006.05.006. Clin Pharmacol Ther. 2006. PMID: 16952490 Clinical Trial.

2

Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.

Frye RF, Branch RA. Frye RF, et al. Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x. Br J Clin Pharmacol. 2002. PMID: 11851639 Free PMC article.

3

Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.

Lee JI, Chaves-Gnecco D, Amico JA, Kroboth PD, Wilson JW, Frye RF. Lee JI, et al. Among authors: frye rf. Clin Pharmacol Ther. 2002 Dec;72(6):718-28. doi: 10.1067/mcp.2002.129068. Clin Pharmacol Ther. 2002. PMID: 12496753 Clinical Trial.

4

Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.

Nolin TD, Gastonguay MR, Bies RR, Matzke GR, Frye RF. Nolin TD, et al. Among authors: frye rf. Clin Pharmacol Ther. 2003 Dec;74(6):555-68. doi: 10.1016/j.clpt.2003.09.003. Clin Pharmacol Ther. 2003. PMID: 14663458 Clinical Trial.

5

Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation.

Liu S, Frye RF, Branch RA, Venkataramanan R, Fung JJ, Burckart GJ. Liu S, et al. Among authors: frye rf. J Clin Pharmacol. 2005 Jun;45(6):666-73. doi: 10.1177/0091270005276202. J Clin Pharmacol. 2005. PMID: 15901748 Clinical Trial.

6

Validation of incorporating flurbiprofen into the Pittsburgh cocktail.

Zgheib NK, Frye RF, Tracy TS, Romkes M, Branch RA. Zgheib NK, et al. Among authors: frye rf. Clin Pharmacol Ther. 2006 Sep;80(3):257-63. doi: 10.1016/j.clpt.2006.06.005. Clin Pharmacol Ther. 2006. PMID: 16952492 Clinical Trial.

7

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes.

Frye RF, Matzke GR, Adedoyin A, Porter JA, Branch RA. Frye RF, et al. Clin Pharmacol Ther. 1997 Oct;62(4):365-76. doi: 10.1016/S0009-9236(97)90114-4. Clin Pharmacol Ther. 1997. PMID: 9357387 Clinical Trial.

8

Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.

Frye RF, Adedoyin A, Mauro K, Matzke GR, Branch RA. Frye RF, et al. J Clin Pharmacol. 1998 Jan;38(1):82-9. doi: 10.1002/j.1552-4604.1998.tb04381.x. J Clin Pharmacol. 1998. PMID: 9597564

9

Effects of liver disease on the disposition of the opioid antagonist nalmefene.

Frye RF, Matzke GR, Schade R, Dixon R, Rabinovitz M. Frye RF, et al. Clin Pharmacol Ther. 1997 Jan;61(1):15-23. doi: 10.1016/S0009-9236(97)90178-8. Clin Pharmacol Ther. 1997. PMID: 9024170

10

Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.

Carcillo JA, Adedoyin A, Burckart GJ, Frye RF, Venkataramanan R, Knoll C, Thummel K, Roskos L, Wilson JW, Sereika S, Romkes M, Bebia Z, Branch RA. Carcillo JA, et al. Among authors: frye rf. Clin Pharmacol Ther. 2003 May;73(5):456-67. doi: 10.1016/s0009-9236(03)00055-9. Clin Pharmacol Ther. 2003. PMID: 12732845 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters